ASTRO Virtual Meeting Center

Log-in / Create Account

Session Information

2008 Annual Meeting

Click here to go to the previous page

Nasopharyngeal Cancer

Track : EDU

Program Code: EDU203

Date: Monday, September 22, 2008

Time: 7:15 AM to 8:45 AM EST

Duration: 4610 Minutes

Location: 107

SPEAKER(S):

Click the plus sign to see more detailed information about each speaker.

Anne Lee, Chief of Service, Pamela Youde Nethersole Eastern Hospital

Professional Achievements Qualification FRCR (UK) 1983 FHKCR (HK) 1992 FHKAM (HK) 1993 Professional Appointments Consultant in Clinical Oncology, since 1991 Cluster Chief of Service, Hong Kong East Cluster, since 2005 Important Academic Appointments The University of Hong Kong Honorary Clinical Associate Professor in Clinical Oncology, since 2000 The Chinese University of Hong Kong Adjunct Associate Professor in Clinical Oncology, 1999-2005 Expert Panel for International Professional / Academic Organizations International Union Against Cancer UICC TNM Expert Advisory Panel on Head and Neck Cancers, since 2001 International Agency for Research on Cancer WHO Classification of Head and Neck Tumours, 2003 American Society for Therapeutic Radiology and Oncology Consultant to the International Relations Committee, since 2000 ASTRO Leadership Team, since 2001 European Society for Medical Oncology ESMO Faculty Member of Nasopharyngecal Cancer, since 2006 Board of Editor for International Professional Journals International Journal of Radiation Oncology, Biology and Physics, since 1998 American Journal of Clinical Oncology, since 1997 Leading Role in Local Professional / Academic Organizations Hong Kong Head and Neck Society Treasurer, 1992-1994 President Elect, 1995 and 2002 President, 1996 and 2003 Council Member, since 2004 Hong Kong Nasopharyngeal Cancer Study Group Vice Chairman, 1999-2003 Chairman, Since 2005 Recent Presentations and Publications Presentations Advances in chemo-radiotherapy for nasopharyngeal carcinoma. 1st Pan-Pearl River Conference, May 2006, Guangzhou, China. The Hong Kong story in the fight against nasopharyngeal cancer. 11th Asian Oceanian Congress of Radiology, August 2006 Hong Kong, China Combined modality treatment for nasopharyngeal carcinoma. 5th Shanghai International Conference on Radiation Oncology, November 2006 Shanghai, China Fitting of biological parameters for tumor control probability of nasopharyngeal carcinoma. Multidisciplinary Head & Neck Cancer Symposium, January 2007, Palms Springs, USA Nasopharyngeal Cancer. 49th American Society for Therapeutic Radiology and Oncology, October 2007, Los Angeles, USA Publications Major Late Toxicities Following Conformal Radiotherapy for Nasopharyngeal Carcinoma-Patient and Treatment Related Risk Factors. Int J Radiat Oncol Biol Phys (in press) Nasopharynx. In Principles and Practice of Radiation Oncology, 5th Edition. Philadelphia: Lippincott Williams & Wilkins, pp 820-857, 2008 Preliminary results of a randomized study (NPC-9902 Trial) on the therapeutic gain by concurrent chemotherapy and/ or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 66(1): 142-151, 2006 Current Management Strategies for Non-Metastatic Nasopharyngeal Cancer. Am J Cancer, 5(6): 383-392, 2006 Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol, 23(28): 6966-6975, 2005. Treatment of stage IV(A-B) Nasopharyngeal Carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation. Int J Radiat Oncol Biol Phys, 63(5): 1331-1338, 2005.

Brian O'Sullivan, M.D., FASTRO, Princess Margaret Hospital

LEARNER OUTCOMES:

Describe the epidemiology, pathology, and natural history, including prognostic factors and staging characteristics, of nasopharyngeal carcinoma.
Review treatment strategies and advances in radiation therapy to optimize loco-regional of nasopharyngeal cancer.
Update on the therapeutic value of chemo-radiotherapy for improvement of distant and loco-regional control in nasopharyngeal cancer.